| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.04B | 66.00B | 65.16B | 64.78B | 65.83B | 66.58B |
| Gross Profit | 17.85B | 17.60B | 17.68B | 15.72B | 17.46B | 19.27B |
| EBITDA | 6.74B | 4.85B | 6.85B | 1.55B | 4.21B | 5.58B |
| Net Income | 2.04B | -1.46B | 1.78B | -2.31B | 365.00M | 1.31B |
Balance Sheet | ||||||
| Total Assets | 103.16B | 104.25B | 102.11B | 101.75B | 97.02B | 95.06B |
| Cash, Cash Equivalents and Short-Term Investments | 4.55B | 4.13B | 5.44B | 5.16B | 4.55B | 5.48B |
| Total Debt | 40.71B | 42.84B | 43.26B | 43.28B | 39.83B | 37.08B |
| Total Liabilities | 57.24B | 58.95B | 56.49B | 57.03B | 52.61B | 50.87B |
| Stockholders Equity | 44.98B | 44.38B | 44.71B | 43.86B | 43.35B | 43.15B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.96B | -440.00M | -933.00M | -3.34B | 940.00M |
| Operating Cash Flow | 0.00 | 2.61B | 3.98B | 4.03B | 109.00M | 4.60B |
| Investing Cash Flow | 0.00 | -5.26B | -3.63B | -5.07B | -2.94B | -3.92B |
| Financing Cash Flow | 0.00 | 1.45B | 71.00M | 1.53B | 1.94B | -3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
65 Neutral | ¥42.51B | 14.96 | ― | 2.97% | 1.99% | -3.72% | |
65 Neutral | ¥7.93B | 4.20 | ― | 1.66% | 16.91% | 1710.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
43 Neutral | ¥8.01B | -5.48 | ― | 2.65% | 1.29% | -181.94% |